Pfizer Stock Slides As Soft Covid Vaccine Sales Outlook Mars Q4 Earnings Beat
"As we turn to 2023, we expect to once again set records, with potentially the largest number of new product and indication launches that weve ever had in such a short period of time," said CEO
Tuesday, January 31, 2023 at 12:50 pm